The neurobiology of the tuberous sclerosis complex

被引:0
作者
Leah Marcotte
Peter B. Crino
机构
[1] University of Pennsylvania Medical Center,Department of Neurology and PENN Epilepsy Center
来源
NeuroMolecular Medicine | 2006年 / 8卷
关键词
Tuberous Sclerosis; Tuberous Sclerosis Complex; Tuberin; Infantile Spasm; NeuroMolecular Medicine Volume;
D O I
暂无
中图分类号
学科分类号
摘要
Tuberous sclerosis complex (TSC) is a multisystem disorder that affects numerous organ systems. Brain lesions that form during development, known as tubers, are highly associated with epilepsy, cognitive disability, and autism. Following the identification of two genes and their encoded proteins, TSC1 (hamartin) and TSC2 (tuberin), responsible for TSC, identification of several downstream protein cascades that might be affected in TSC have been discovered. Of primary importance is the mammalian target of rapamycin pathway that controls cell growth and protein synthesis. The mechanisms governing brain lesion growth have not been fully identified but likely altered regulation of the mammalian target of rapamycin cascade by hamartin and tuberin during development leads to aberrant cell growth. Secondary effects of TSC gene mutations might disrupt normal neuronal migration and cerebral cortical lamination. Numerous studies have identified changes in gene and protein expression in animal models of TSC and in human TSC brain specimens that contribute to altered brain cytoarchitecture. This review will provide an overview of the neurobiological aspects of TSC.
引用
收藏
页码:531 / 546
页数:15
相关论文
共 340 条
[1]  
Astridinis A.(2005)Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease Oncogene 24 7475-7481
[2]  
Henske E. P.(2003)Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B J. Biol. Chem. 278 51,372-51,379
[3]  
Astrinidis A.(1999)MR imaging of tuberous sclerosis in neonates and young infants AJNR Am. J. Neuroradiol. 20 907-916
[4]  
Senapedis W.(2004)mTOR Cascade Activation Distinguishes Tubers from Focal Cortical Dysplasia Ann. Neurol. 56 478-487
[5]  
Coleman T. R.(2004)Tuberous Sclerosis Complex 2 Gene Product Interacts with Human SMAD Proteins: a molecular link of two tumor suppressor pathways J. Biol. Chem. 279 25,605-25,613
[6]  
Henske E. P.(2001)Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B J. Neuropathol. Exp. Neurol. 60 711-723
[7]  
Baron Y.(2004)Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation J. Neuropathol. Exp. Neurol. 63 1236-1242
[8]  
Barkovich A. J.(1998)Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography Ann. Neurol. 44 858-866
[9]  
Baybis M.(1993)Identification and characterization of the tuberous sclerosis gene on chromosome 16 Cell 75 1305-1315
[10]  
Yu J.(1999)New developments in the neurobiology of the tuberous sclerosis complex Neurology 53 1384-1390